The Duke of York visited the Churchill Hospital in Oxford today to mark the opening of the new building. The building, that includes an integrated Cancer and Haematology Centre, provides a base for many NIHR Oxford Biomedical Research Centre projects. Chairman of Oxford University Hospitals NHS Trust, Dame Fiona Caldicott said: “We were absolutely delighted … Read more
News for Multi-Modal Cancer Therapies
Trial to investigate new drug combination in lung cancer
Cancer Research UK’s Drug Development Office has opened the first trial of a new drug combination in patients with advanced solid tumours and in a subset of patients who have non-small cell lung cancer. This trial will combine two compounds that aim to starve the tumours while simultaneously blocking cancer cell growth. The study will … Read more
Can daily aspirin help prevent and treat cancer?
A collection of three papers (two published in The Lancet and one in The Lancet Oncology) add to the growing evidence base suggesting that daily aspirin can be used to help prevent and possibly treat cancer. All three papers are by Professor Peter Rothwell, University of Oxford and John Radcliffe Hospital, and colleagues. The case for using aspirin to prevent cancer continues to build, … Read more
Research@Oxford – Improving Health
On 14th March 2012 the NIHR Biomedical Research Centre and the Oxford Cancer Research Centre (right) hosted a public open day on research that is designed to improve health. A morning session was held for secondary schools, introducing them to the world of cancer research. Scientists, doctors, nurses and technicians were on hand to demonstrate the latest … Read more
New treatment for lung, liver and renal tumours
Doctors, surgeons and researchers from the Imaging Theme of the NIHR Biomedical Research Centre, Oxford are looking into the effectiveness of using ablation as another treatment option for lung, liver and renal tumours. Microwave Ablation is used to treat small tumors by passing a needle-like probe inside the tumour. The microwaves released from the probe increase the temperature within tumour tissue that … Read more
Ten years of collaboration brings new hope for patients
NIHR funded doctors, surgeons and scientists from the HIFU Unit (high intensity focused ultrasound), marked its official opening at the Churchill Hospital after a 10 year collaboration with the Haifu Company of China. The £1.5m Oxford HIFU machine has been given on long-term loan from the Haifu Company and was recently used to treat 72 year old David Atwell, … Read more
Researchers trial new drug for women with hereditary breast and ovarian cancer
A CANCER RESEARCH UK-funded trial of a new drug for patients with advanced breast or ovarian cancer due to inherited gene faults has been launched at the Oxford Experimental Cancer Medicine Centre (ECMC) at the University of Oxford. The trial, led by a team based at the National Institute for Health Research (NIHR) Oxford Biomedical Research … Read more
Small molecules found to play complex role in cancer metastasis
While they may be small in size, a family of tiny molecules called microRNAs could potentially play a large role in the process of cancer metastasis, or the spread of cancer from one area of the body to another. A team of researchers from The Cancer Institute of New Jersey (CINJ) and Princeton University, along … Read more
Rare tumour’s ‘fingerprint’ used to develop cheap and reliable new test
Researchers at the University of Oxford have developed a cheap and reliable diagnostic test for a rare form of cancer. The test involves screening tumour samples for a particular molecular fingerprint unique to this cancer. Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a disorder that causes the development of benign but often painful tumours … Read more
ARCII-study in Oxford – the human face of medical breakthrough
Last December, Kevin Jones, a 43-year-old businessman from Dorset was diagnosed with pancreatic cancer. It was advanced and inoperable. Today, as he prepares to celebrate Christmas with his son, Mr Jones is free from any detectable trace of the disease; the human face of a medical breakthrough so exciting that the scientists involved struggle to … Read more